Register for our free email digests:
Boston Scientific Corp.
www.bostonscientific.com
Latest From Boston Scientific Corp.
Market Intel: Let's Talk About It — The Rising Tide Of 'Femtech' Companies
Femtech, which describes digital technologies that aim to improve women's health, is expected to reach $50bn in market size by 2025, according to Frost & Sullivan. Reproductive health and menstrual health trackers are two of the fastest-growing sectors in femtech. We've highlighted some of the biggest players in both segments, their innovative business models, plans and also looked at barriers such as privacy issues, accuracy of mobile applications and funding challenges.
Medtechs Ready To Take Creative Approach To Deal-Making With An Eye On Start-Ups
Ground-breaking M&A deals were largely absent from medtech industry schedules in 2018 – Boston’s BTG deal aside – but that does not mean consolidation of the medtech industry is slowing down. M&A deal numbers have been steady of late, even if aggregate deal value has declined in recent years. Digital transformation is a catalyst for a growing number of sector-transforming transactions.
SCAI, Manufacturers Defend Peripheral Paclitaxel Devices Against Doubts
The Society for Cardiovascular Angiography and Interventions’ Vascular Disease Council says the recent meta-analysis finding a higher long-term mortality risk with paclitaxel-eluting peripheral devices can only be viewed as hypothesis-generating. The long-term risks of these devices should be investigated with patient-level data, SCAI argues. Several clinical data presentations at the recent LINC meeting in Leipzig showed comparable mortality rates with paclitaxel-eluting devices as comparable non-drug-eluting devices.
Starts & Stops: Boston Scientific Launches New Lotus TAVR Trial, Medtronic Starts Study Of SynchroMed II Pain Pump
Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by MedDeviceTracker. This edition covers trial announcements from Jan. 7 through Jan. 27, including announcements from Medtronic, QT Vascular, Boston Scientific, and Shockwave.
Company Information
- Industry
-
Medical Devices
- Implantable Devices
- Monitoring Equipment & Devices
- Rehabilitation Equipment and Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gynecological, Urological
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- Respiratory, Pulmonary
- Alias(es)
- Cardiovascular Imaging Systems (CVIS)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
-
Boston Scientific Corp.
- Advanced Stent Technologies Inc.
- Apama Medical Inc.
- Asthmatx Inc.
- Atritech Inc.
- Augmenix Inc.
- Bard Electrophysiology
- BEI Medical Systems Co. Inc.
- Boston Scientific Japan KK
- BridgePoint Medical Inc.
- Cameron Health Inc.
- Cardiac Pathways Corp.
- CardioGene Therapeutics Inc.
- Cardiovascular Imaging Systems Inc.
- Catheter Innovations Inc.
- Claret Medical Inc.
- Corvita Corp.
- CryoCor Inc.
- CryoVascular Systems Inc.
- Embolic Protection Inc.
- EndoChoice Holdings Inc.
- EndoTex Interventional Systems Inc.
- Enteric Medical Technologies Inc.
- EP Technologies Inc.
- Guidant Corp.
- Heart Technology Inc.
- InFlow Dynamics Inc.
- IntElect Medical Inc.
- Interventional Technologies Inc.
- IoGyn Inc.
- Labcoat Ltd.
- Mansfield
- Mansfield EP
- Meadox Medicals Inc.
- Microvasive Inc.
- MinTec
- nVision Medical Corp.
- Possis Medical Inc.
- Precision Vascular Systems Inc.
- Quanam Medical Corp.
- RadioTherapeutics Corp.
- Remon Medical Technologies Ltd.
- ReVascular Therapeutics Inc.
- Rhythmia Medical Inc.
- Rubicon Medical Corp.
- Sadra Medical Inc.
- Schneider Worldwide
- SciMed Life Systems Inc.
- Securus Medical Group Inc.
- Smart Therapeutics Inc.
- Symbiosis Corp.
- Symetis SA
- Target Therapeutics Inc.
- Veniti Inc.
- Vesica Medical Inc.
- Vessix Vascular Inc.
- XLumena Inc.
- Senior Management
-
Michael F Mahoney, Chmn. & CEO
Daniel J Brennan, EVP, CFO
Ian Meredith, EVP, Global CMO
Edward Mackey, MD, PhD, EVP, Global Operations - Contact Info
-
Boston Scientific Corp.
Phone: (508) 683-4000
300 Boston Scientific Way
Marlborough, MA 01752-1234
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice